-+ 0.00%
-+ 0.00%
-+ 0.00%

Biomerica Expands CDMO Services To Meet Rising Demand From Diagnostic And Biotech Companies

Benzinga·11/06/2025 13:38:20
Listen to the news
  • Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service Expansion
  • Comprehensive CDMO services now featured on Biomerica's updated website

IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced medical diagnostic solutions, today announced the expansion of its Contract Development and Manufacturing Organization (CDMO) services to meet accelerating market demand. The Company is enhancing its capabilities to provide greater value and reliability of product development and manufacturing across the entire development lifecycle for diagnostic innovators worldwide.

With more than 40 years of expertise in assay development, manufacturing, and regulatory compliance, Biomerica is increasingly being approached by biotechnology and diagnostic companies seeking a proven partner to accelerate innovation and scale manufacturing. The Company's CDMO services are a growing contributor to revenue and represent an opportunity for growth.